B. Watson

发表

Performance of an algorithm for assessing smallpox risk among patients with rashes that may be confused with smallpox.

E. Lerner, W. Schaffner, J. Meek, 2008, Clinical Infectious Diseases.

Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection.

R. Keren, C. Bridges, D. Licht, 2005, JAMA.

Incidence, Complications, and Risk Factors for Prolonged Stay in Children Hospitalized With Community-Acquired Influenza

R. Keren, C. Bridges, S. Coffin, 2007, Pediatrics.

Varicella disease after introduction of varicella vaccine in the United States, 1995-2000.

L. Mascola, M. Wharton, K. Brodovicz, 2002, JAMA.

Impact of a Routine Two-Dose Varicella Vaccination Program on Varicella Epidemiology

L. Mascola, S. Bialek, B. Watson, 2013, Pediatrics.

Transmission of varicella zoster virus from individuals with herpes zoster or varicella in school and day care settings.

S. Bialek, B. Watson, C. Newbern, 2012, The Journal of infectious diseases.

Varicella in Infants After Implementation of the US Varicella Vaccination Program

L. Mascola, J. Seward, B. Watson, 2011, Pediatrics.

Evaluation of laboratory methods for diagnosis of varicella.

R. Harpaz, V. Loparev, J. Leung, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Varicella among adults: data from an active surveillance project, 1995-2005.

L. Mascola, J. Seward, B. Watson, 2008, The Journal of infectious diseases.

Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.

L. Mascola, J. Seward, P. Gargiullo, 2008, The Journal of infectious diseases.

Epidemiology of varicella hospitalizations in the United States, 1995-2005.

J. Seward, B. Watson, A. Jumaan, 2008, The Journal of infectious diseases.

Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.

B. Watson, 2008, The Journal of infectious diseases.

Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005.

J. Seward, B. Watson, S. Chaves, 2008, The Journal of infectious diseases.

Validity of Self-Reported Varicella Disease History in Pregnant Women Attending Prenatal Clinics

L. Mascola, S. Schmid, B. Watson, 2007, Public health reports.

Varicella-zoster vaccine in the USA: success for control of disease severity, but what next?

B. Watson, 2005, Expert review of anti-infective therapy.

Chickenpox or smallpox: the use of the febrile prodrome as a distinguishing characteristic.

J. Seward, B. Watson, A. Jumaan, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Varicella: a vaccine preventable disease?

B. Watson, 2002, The Journal of infection.

Modified chickenpox in children immunized with the Oka/Merck varicella vaccine.

S. Plotkin, B. Watson, S. Starr, 1993, Pediatrics.

Do laws bring children in child care centers up to date for immunizations?

M. Kolasa, J. Rosenthal, B. Watson, 2003, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.

Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization.

E. Rothstein, K. Reisinger, D. Clements, 1995, The Journal of infectious diseases.

Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine.

A. Cnaan, D. Olaleye, B. Watson, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children.

B. Watson, B. Kuter, C. White, 1996, The Journal of infectious diseases.

Safety and immunogenicity of acellular pertussis vaccine, combined with diphtheria and tetanus as the Japanese commercial Takeda vaccine, compared with the Takeda acellular pertussis component combined with Lederle's diphtheria and tetanus toxoids in two-, four- and six-month-old infants.

B. Watson, J. Hackell, A. Cawein, 1992, The Pediatric Infectious Disease Journal.

Routine Laboratory Testing Data for Surveillance of Rotavirus Hospitalizations to Evaluate the Impact of Vaccination

Manish M Patel, R. Glass, J. Tate, 2007, The Pediatric infectious disease journal.

Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors.

R. Keren, D. Licht, S. Coffin, 2007, The Journal of pediatrics.

Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.

E. Rothstein, K. Reisinger, H. Bernstein, 1993, Pediatrics.

Varicella vaccine: progress 4 years after licensure.

E. Rothstein, B. Watson, 1999, Pediatric annals.

Varicella vaccine for healthy children

B. Watson, S. Starr, 1994, The Lancet.

Tolerability of rifampin monotherapy for latent tuberculosis infection in children.

B. Watson, Irini Daskalaki, M. C. Dogbey, 2011, The Pediatric infectious disease journal.

Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine.

D. West, B. Watson, S. Piercy, 2001, Vaccine.

Validity of Reported Varicella History as a Marker for Varicella Zoster Virus Immunity Among Unvaccinated Children, Adolescents, and Young Adults in the Post–Vaccine Licensure Era

A. Fiks, P. Gargiullo, D. Schmid, 2009, Pediatrics.

Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity.

P. Keller, B. Watson, R. Ellis, 1990, The Journal of infectious diseases.

Varicella immunity in vaccinated healthcare workers.

D. Schmid, B. Watson, A. Behrman, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Safety and Immunogenicity of a Combined Live Attenuated Measles, Mumps, Rubella, and Varicella Vaccine (MMRIIV) in Healthy Children

B. Watson, B. Kuter, B. Staehle, 1996 .

Incremental Effectiveness of Second Dose Varicella Vaccination for Outbreak Control at an Elementary School in Philadelphia, Pennsylvania, 2006

B. Watson, M. Marin, C. Spain, 2010, The Pediatric infectious disease journal.

Comparing Active and Passive Varicella Surveillance in Philadelphia, 2005–2010: Recommendations for the Transition to Nationwide Passive Varicella Disease Surveillance

S. Bialek, B. Watson, Kendra M. Viner, 2014, Public health reports.

Validity of medical record documented varicella-zoster virus among unvaccinated cohorts

A. Fiks, D. Schmid, B. Watson, 2013, Human vaccines & immunotherapeutics.

Knowledge, Attitudes, and Practices for Diagnosing Breakthrough Varicella in the Outpatient Setting

Caroline C. Johnson, E. Newbern, B. Watson, 2009, Public health reports.

A Cluster of Primary Varicella Cases Among Healthcare Workers With False-Positive Varicella Zoster Virus Titers

D. Schmid, B. Watson, A. Behrman, 2003, Infection Control & Hospital Epidemiology.

HUMORAL AND CELL-MEDIATED IMMUNE RESPONSES IN HEALTHY CHILDREN AFTER ONE OR TWO DOSES OF VARICELLA VACCINE

B. Watson, 1995 .

Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine.

T. Randall, B. Watson, S. Starr, 1994, The Journal of infectious diseases.

The effect of decreasing amounts of live virus, while antigen content remains constant, on immunogenicity of Oka/Merck varicella vaccine.

B. Watson, B. Kuter, S. Starr, 1993, The Journal of infectious diseases.

Pulmonary Mycobacterium gordonae infection in a two-year-old child: case report.

M. Hogarty, K. McGowan, K. McGowan, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.